BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23775920)

  • 1. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
    Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
    Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins.
    Hopcraft SE; Evans MJ
    Hepatology; 2015 Oct; 62(4):1059-69. PubMed ID: 25820616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.
    Zheng A; Yuan F; Li Y; Zhu F; Hou P; Li J; Song X; Ding M; Deng H
    J Virol; 2007 Nov; 81(22):12465-71. PubMed ID: 17804490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
    PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.
    Haid S; Windisch MP; Bartenschlager R; Pietschmann T
    J Virol; 2010 Jan; 84(2):964-75. PubMed ID: 19889758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
    Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
    J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection.
    Shirasago Y; Fukazawa H; Nagase S; Shimizu Y; Mizukami T; Wakita T; Suzuki T; Tani H; Kondoh M; Kuroda T; Yasuda S; Sato Y; Hanada K; Fukasawa M
    Sci Rep; 2022 Nov; 12(1):20243. PubMed ID: 36424447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape.
    Colpitts CC; Tawar RG; Mailly L; Thumann C; Heydmann L; Durand SC; Xiao F; Robinet E; Pessaux P; Zeisel MB; Baumert TF
    Gut; 2018 Apr; 67(4):736-745. PubMed ID: 28360099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
    Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J
    J Virol; 2018 May; 92(10):. PubMed ID: 29491159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
    Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
    Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
    Fukasawa M; Nagase S; Shirasago Y; Iida M; Yamashita M; Endo K; Yagi K; Suzuki T; Wakita T; Hanada K; Kuniyasu H; Kondoh M
    J Virol; 2015 May; 89(9):4866-79. PubMed ID: 25673725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
    Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
    PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus.
    Yang W; Qiu C; Biswas N; Jin J; Watkins SC; Montelaro RC; Coyne CB; Wang T
    J Biol Chem; 2008 Mar; 283(13):8643-53. PubMed ID: 18211898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
    Sarhan MA; Chen AY; Michalak TI
    PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties.
    Tawar RG; Colpitts CC; Timm J; Fehm T; Roggendorf M; Meisel H; Meyer N; Habersetzer F; Cosset FL; Berg T; Zeisel MB; Baumert TF
    Hepatology; 2015 Sep; 62(3):726-36. PubMed ID: 26010076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
    Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
    J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection of neuroepithelioma cell lines.
    Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F
    Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudins and pathogenesis of viral infection.
    Tawar RG; Colpitts CC; Lupberger J; El-Saghire H; Zeisel MB; Baumert TF
    Semin Cell Dev Biol; 2015 Jun; 42():39-46. PubMed ID: 25960372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.
    Ploss A; Evans MJ; Gaysinskaya VA; Panis M; You H; de Jong YP; Rice CM
    Nature; 2009 Feb; 457(7231):882-6. PubMed ID: 19182773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
    Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.